• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/70 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 211/70

Total number of patents in this class: 241

10-year publication summary

16
22
10
24
12
18
11
13
7
1
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
ChemoCentryx, Inc.
400
11
Pfizer Inc.
3322
5
Coral Sunscreen Pty Ltd
5
5
Taisho Pharmaceutical Co., Ltd.
844
5
Toyama Chemical Co., Ltd.
114
5
The United States of America, as represented by the Secretary, Department of Health and Human Services
2737
5
Boehringer Ingelheim International GmbH
4629
4
Florida State University Research Foundation, Inc.
685
4
Global Blood Therapeutics, Inc.
180
4
National Institute of Biological Sciences, Beijing
91
4
The Wistar Institute of Anatomy and Biology
387
4
AstraZeneca AB
3042
3
Janssen Pharmaceutica N.V.
3839
3
Massachusetts Institute of Technology
9795
3
The Broad Institute, Inc.
1584
3
Dong-A ST Co., Ltd.
129
3
Incyte Holdings Corporation
609
3
Shionogi & Co., Ltd.
914
3
Prilenia Neurotherapeutics Ltd.
83
3
Corteva Agriscience LLC
2494
3
Other owners 158